- Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men
-
Saad F, Yassin A, Haider A, Doros G, Gooren L
- KMID: 2155307
- Korean J Urol.
- 2015 Apr;56(4):310-317.
- doi: 10.4111/kju.2015.56.4.310
PURPOSE: To investigate the potential benefits of testosterone administration to elderly men (>65 years) with late-onset hypogonadism (LOH) in comparison with younger men and to assess the safety of testosterone... -
- CITED
-
- Close
- SHARE
-
- Close
- How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?
-
Kim JH, Song YB, Shin DH, Kim JS, Choi JO, On YK, Kim JS
- KMID: 1782972
- Yonsei Med J.
- 2009 Feb;50(1):83-88.
- doi: 10.3349/ymj.2009.50.1.83
PURPOSE: Although warfarin is an effective oral anticoagulation (OAC) drug to reduce the risk of thromboembolism in patients with non-valvular atrial fibrillation (NVAF), long term follow-up data are scarce to... -
- CITED
-
- Close
- SHARE
-
- Close
- A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome
-
Lee JH, Ahn SG, Park B, Park SW, Kang YS, Lee JW, Youn YJ, Ahn MS, Kim JY, Yoo BS, Lee SH, Yoon J
- KMID: 2381560
- Korean J Intern Med.
- 2015 Sep;30(5):620-628.
- doi: 10.3904/kjim.2015.30.5.620
BACKGROUND/AIMS: Newer P2Y12 inhibitors, such as prasugrel and ticagrelor, have greater antiplatelet efficacy but may increase the risk of bleeding. In this study, we compared the pharmacodynamic efficacy of prasugrel... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians
-
Park JY, Rha SW, Choi BG, Choi SY, Choi JW, Ryu SK, Lee SJ, Kim S, Noh YK, Akkala RG, Li H, Ali J, Kim JB, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ
- KMID: 2466368
- Yonsei Med J.
- 2016 Jan;57(1):180-186.
- doi: 10.3349/ymj.2016.57.1.180
PURPOSE: Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) are associated with a decreased incidence of new-onset diabetes mellitus (NODM). The aim of this study was to compare... -
- CITED
-
- Close
- SHARE
-
- Close
